PDPL — Parenteral Drugs (India) Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro Cap

Annual balance sheet for Parenteral Drugs (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2018 March 31st	2019 March 31st	2020 March 31st	R2021 March 31st	2022 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	PRESS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	35.5	4.46	1.08	0.57	0.001
Net Total Accounts Receivable
Net Total Receivables	660	57	90.4	90.9	92.5
Total Inventory
Total Other Current Assets
Total Current Assets	990	673	675	678	671
Net Property, Plant And Equipment	7,158	3,565	3,391	3,218	2,054
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	8,904	5,406	5,519	5,679	4,842
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5,926	8,775	10,057	11,433	12,008
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	10,269	9,875	11,132	12,508	13,083
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	-1,364	-4,469	-5,613	-6,829	-8,240
Total Liabilities & Shareholders' Equity	8,904	5,406	5,519	5,679	4,842
Total Common Shares Outstanding